Brian N. Cherry
Director · Atara Biotherapeutics, Inc.
IndividualBuying only
- 2026
- Sep 4, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian N. Cherry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $4.74M in ATRA purchases and sales in the last 12 months
- Panacea Innovation Ltd - $3.65M in ATRA purchases and sales in the last 12 months
- Anhco Nguyen - $142K in ATRA purchases and sales in the last 12 months
- Yanina Grant-Huerta - $57K in ATRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian N. Cherry?
Brian N. Cherry is a corporate insider, tracked as Director of Atara Biotherapeutics, Inc. (ATRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian N. Cherry submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Brian N. Cherry been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1000K) and 0 open-market sales across all tracked filings.
